Anna P Friedman

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Diabetic Retinopathy

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew A Murray, Katelyn J Noronha, Yazhe Wang, Anna P Friedman, Sateja Paradkar, Hee Won Suh, Ranjini K Sundaram, Charles Brenner, W Mark Saltzman, Ranjit S Bindra
Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors. Molecular cancer therapeutics 23 (8) (2024)
Matthew A Murray, Katelyn J Noronha, Yazhe Wang, Anna P Friedman, Sateja Paradkar, Hee Won Suh, Ranjini K Sundaram, Charles Brenner, W Mark Saltzman, Ranjit S Bindra
Exploiting Metabolic Defects in Glioma with Nanoparticle Encapsulated NAMPT Inhibitors. Molecular cancer therapeutics (2024)
Matthew A Murray, Katelyn J Noronha, Yazhe Wang, Anna P Friedman, Sateja Paradkar, Hee Won Suh, Ranjini K Sundaram, Charles Brenner, W Mark Saltzman, Ranjit S Bindra
Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors. Molecular cancer therapeutics 23 (8) (2024)
Matthew A Murray, Katelyn J Noronha, Yazhe Wang, Anna P Friedman, Sateja Paradkar, Hee Won Suh, Ranjini K Sundaram, Charles Brenner, W Mark Saltzman, Ranjit S Bindra
Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors. Molecular cancer therapeutics 23 (8) (2024)
Matthew A Murray, Katelyn J Noronha, Yazhe Wang, Anna P Friedman, Sateja Paradkar, Hee Won Suh, Ranjini K Sundaram, Charles Brenner, W Mark Saltzman, Ranjit S Bindra
Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors. Molecular cancer therapeutics 23 (8) (2024)